Looks to me like they will hit the 30s. Very depressing. One can only average down so much. At 40c the company is valued at $400m approx on a $2b project and still needs another $200m to finish-half the market cap.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%